| Autophagy in Disease and Therapy | Lifetime | 23 | CN 2 | 99.81 |
| Adipose Tissue and Metabolism | Lifetime | 77 | CN 3 | 99.74 |
| Cardiovascular Function and Risk Factors | Lifetime | 96 | CN 1 | 99.80 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 38 | CN 1 | 99.57 |
| Alcohol Consumption and Health Effects | Lifetime | 48 | CN 2 | 99.30 |
| Cardiac Ischemia and Reperfusion | Lifetime | 69 | CN 1 | 99.31 |
| Metabolism, Diabetes, and Cancer | Lifetime | 106 | CN 2 | 99.46 |
| Mitochondrial Function and Pathology | Lifetime | 187 | CN 4 | 99.20 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 27 | CN 2 | 99.14 |
| Neuroscience of respiration and sleep | Lifetime | 147 | CN 2 | 99.06 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 253 | CN 3 | 99.28 |
| Pancreatic function and diabetes | Lifetime | 373 | CN 4 | 98.86 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 65 | CN 1 | 98.31 |
| Cardiovascular Disease and Adiposity | Lifetime | 309 | CN 5 | 98.33 |
| Nitric Oxide and Endothelin Effects | Lifetime | 367 | CN 10 | 98.40 |
| Birth, Development, and Health | Lifetime | 726 | CN 19 | 98.07 |
| Advanced Glycation End Products research | Lifetime | 199 | CN 19 | 97.16 |
| Ferroptosis and cancer prognosis | Lifetime | 387 | CN 198 | 95.85 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 649 | CN 11 | 97.37 |
| Macrophage Migration Inhibitory Factor | Lifetime | 99 | CN 3 | 96.11 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 623 | CN 20 | 96.51 |
| Cardiomyopathy and Myosin Studies | Lifetime | 757 | CN 6 | 96.62 |
| Apelin-related biomedical research | Lifetime | 193 | CN 8 | 94.54 |
| Regulation of Appetite and Obesity | Lifetime | 738 | CN 16 | 96.07 |
| Trace Elements in Health | Lifetime | 861 | CN 42 | 95.85 |
| Electron Spin Resonance Studies | Lifetime | 666 | CN 17 | 95.15 |
| Vitamin C and Antioxidants Research | Lifetime | 450 | CN 3 | 94.50 |
| Alcoholism and Thiamine Deficiency | Lifetime | 317 | CN 5 | 93.10 |
| Cardiac Fibrosis and Remodeling | Lifetime | 535 | CN 44 | 93.51 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 799 | CN 36 | 93.18 |
| Calpain Protease Function and Regulation | Lifetime | 266 | CN 10 | 89.93 |
| Protein Tyrosine Phosphatases | Lifetime | 697 | CN 55 | 88.43 |
| Calcium signaling and nucleotide metabolism | Lifetime | 622 | CN 33 | 89.10 |
| Paraquat toxicity studies and treatments | Lifetime | 135 | CN 19 | 85.65 |
| Coenzyme Q10 studies and effects | Lifetime | 581 | CN 22 | 82.70 |
| GDF15 and Related Biomarkers | Lifetime | 897 | CN 79 | 74.21 |
| Autophagy in Disease and Therapy | 2021-2025 | 4 | CN 2 | 99.73 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 4 | CN 1 | 99.39 |
| Mitochondrial Function and Pathology | 2021-2025 | 22 | CN 3 | 98.62 |
| Adipose Tissue and Metabolism | 2021-2025 | 29 | CN 8 | 98.56 |
| Ferroptosis and cancer prognosis | 2021-2025 | 155 | CN 121 | 97.36 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 36 | CN 2 | 97.08 |
| RNA modifications and cancer | 2021-2025 | 444 | CN 297 | 96.25 |
| Inflammasome and immune disorders | 2021-2025 | 166 | CN 82 | 93.63 |
| Trace Elements in Health | 2021-2025 | 131 | CN 44 | 92.38 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 988 | CN 47 | 94.03 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 669 | CN 262 | 86.90 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 433 | CN 81 | 85.21 |
| Alcohol Consumption and Health Effects | 2021-2025 | 679 | CN 76 | 80.52 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 368 | CN 117 | 75.60 |
| Electron Spin Resonance Studies | 2021-2025 | 324 | CN 51 | 78.69 |
| Renin-Angiotensin System Studies | 2021-2025 | 154 | CN 13 | 73.76 |
| Nuclear Receptors and Signaling | 2021-2025 | 269 | CN 60 | 72.28 |
| RNA regulation and disease | 2021-2025 | 898 | CN 213 | 69.78 |
| ATP Synthase and ATPases Research | 2021-2025 | 446 | CN 55 | 71.67 |
| Calcium signaling and nucleotide metabolism | 2021-2025 | 211 | CN 34 | 70.44 |
| Sirtuins and Resveratrol in Medicine | 2021-2025 | 519 | CN 169 | 65.74 |
| Telomeres, Telomerase, and Senescence | 2021-2025 | 714 | CN 96 | 65.33 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 189 | CN 55 | 63.17 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | 2021-2025 | 293 | CN 73 | 60.76 |
| GDF15 and Related Biomarkers | 2021-2025 | 476 | CN 76 | 59.50 |
| Nitric Oxide and Endothelin Effects | 2021-2025 | 869 | CN 191 | 53.85 |
